GFFFX
Price
$87.51
Change
+$0.48 (+0.55%)
Updated
Sep 11 closing price
Net Assets
353.07B
NGRDX
Price
$31.90
Change
+$0.23 (+0.73%)
Updated
Sep 11 closing price
Net Assets
2.59B
Interact to see
Advertisement

GFFFX vs NGRDX

GFFFX vs NGRDX Comparison Chart in %
View a ticker or compare two or three
VS
GFFFX vs. NGRDX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFFFX is a Buy and NGRDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 353B vs. NGRDX (2.59B). GFFFX pays higher dividends than NGRDX: GFFFX (0.42) vs NGRDX (0.00). GFFFX was incepted earlier than NGRDX: GFFFX (18 years) vs NGRDX (7 years). NGRDX (0.56) is less costly to investors than GFFFX (0.40). GFFFX is a more actively managed with annual turnover of: 32.00 vs. NGRDX (30.00). NGRDX has a lower initial minimum investment than GFFFX: NGRDX (0) vs GFFFX (250). GFFFX annual gain was more profitable for investors over the last year : 0.34 vs. NGRDX (-3.37). GFFFX return over 5 years is better than : 14.35 vs. NGRDX (11.29).
GFFFXNGRDXGFFFX / NGRDX
Total Expense Ratio0.400.5573%
Annual Report Gross Expense Ratio0.400.5671%
Fund Existence18 years7 years-
Gain YTD9.2377.299127%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets353B2.59B13,629%
Annual Yield % from dividends0.420.00-
Returns for 1 year0.34-3.37-10%
Returns for 3 years44.0033.88130%
Returns for 5 years14.3511.29127%
Returns for 10 years108.77N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MSSM58.610.43
+0.73%
Morgan Stanley Pathway Sm-Md Cp Eq ETF
DRUP67.790.36
+0.54%
GraniteShares Nasdaq Sel Disruptors ETF
IOPP26.51N/A
N/A
Simplify Tara India Opportunities ETF
HYXF45.93-0.08
-0.17%
iShares ESG Advanced Hi Yld Corp Bd ETF
XBI156.20-0.62
-0.40%
State Street® SPDR® S&P® Biotech ETF